Digital Pathology Market predicted to reach USD 17.28 billion by 2030 with a CAGR of 11.9% from 2021-2030

The Global Digital Pathology Market was valued at USD 4.96 billion in 2019 and is estimated to reach USD 17.28 billion by 2030, expanding at a CAGR of 11.9% during the forecast period from 2020 to 2030.

Digital pathology is also known as digital imaging, virtual slides, or virtual microscopy. It is a dynamic image-based environment that helps in the procurement, administration, and interpretation of pathological information by using a computer. It helps pathologist observe slides under a microscope and digitize the images using an image analysis software. Digital pathology provides live and high-resolution images that aid pathologist to diagnose better.

The adoption of digital pathology has increased in numerous applications such as diagnosis of diseases, research, and drug discovery. Also, the demand for digital pathology has increased due to the rising occurrence of chronic diseases around the world.

Access Full Description of this report at:-

https://www.nextmsc.com/report/digital-pathology-market

Top Companies: Danaher Corporation, 3Dhistech Limited, Glencoe software, Hamamatsu Photonics KK, Indica labs Inc., Koninklijke Phillips NV, Nikon Corporation, PerkinElmer Inc., Roche, Visiopharm A/S

Market Dynamics and Trends

Rising prevalence of chronic diseases, increasing demand for the implementation of rapid diagnostic tools, and surging trend of digitization in the medical sector are driving the digital pathology market. Also, growing adoption of digital pathology for disease diagnosis, increasing government support, and ease of consultation have contributed to the growth of digital pathology market.

However, high cost, lack of reimbursements and unwillingness of older pathologists to switch to newer diagnostic tools are factors expected to hinder the digital pathology market growth. On the other hand, increasing awareness regarding the advantages of digital pathology, introduction of affordable scanners for private pathology practices, and increasing requirement for personalized medicine are creating new opportunities in the market.

Request sample copy of this report at:-

https://www.nextmsc.com/Digital-Pathology-Market/request-sample

Market Segmentations and Scope of the Study:

The global digital pathology market share has been segmented on the basis of product, application, end user and geography. On the basis of product, the market is categorized into scanners, software and storage and communication systems. On the basis of application, the market is segmented into teleconsultation, disease diagnosis, drug discovery and training & education. On the basis of end user, the market is segmented into educational, clinical and pharma & biotech companies. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.

Geographical Analysis

The North America region is anticipated to hold the highest market share owing to the increasing adoption of digital pathology, increase in R&D investments, presence of big market players and high consumer awareness are among other factors expected to enhance market growth in this region.

However, Asia Pacific region is predicted to show rapid and consistent growth in market share within the forecast period. This is attributed to the factors such as developments in healthcare facilities, increasing adoption of advanced imaging modalities, and penetration of multi-national companies in the region to harness the untapped potential.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.